Please use this identifier to cite or link to this item: https://hdl.handle.net/10419/240828 
Year of Publication: 
2021
Series/Report no.: 
Texto para Discussão No. 2634
Publisher: 
Instituto de Pesquisa Econômica Aplicada (IPEA), Brasília
Abstract (Translated): 
The objective of this text is to analyze the contribution of the main drivers of the direct expenditure of the Ministry of Health (MS) in medicines that are part of the list of Pharmaceutical Assistance Programs (PAP) from 2010 to 2019. Acquisitions data included in the information system called SIASG were used. The drugs were categorized according to the ATC/DDD (Anatomical Therapeutic Chemical Classification System/ Defined Daily Doses) of the World Health Organization. The physical units of purchase of the products were transformed into the number of defined daily doses (DDD) for each drug. And the unit price was converted to price per DDD. With the support of RStudio software version 1.3.1056 and the statistical package IndexNumR, the contribution of the main drivers of expenditure on medicines was measured: price, quantity, and residuals (therapeutic choices). The results show a wide variation in the expenditure of the Ministry of Health on medicines in the list of PAP from 2010 to 2019, with a greater or lesser contribution of each main driver in the observed oscillation. However, it is important to note the expenditure reduction in some years, mainly driven by a decrease in the quantity of drugs purchased in two consecutive years, which may result in a drop in the availability of these products in the Unified Health System.
Subjects: 
drug expenditure
drivers
pharmaceutical preparations
Unified Health System
health expenditures
JEL: 
H51
Persistent Identifier of the first edition: 
Document Type: 
Working Paper

Files in This Item:
File
Size
959.21 kB





Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.